isoxazoles has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasco-Morente, G; Notario-Ferreira, I; Rueda-Villafranca, B; Tercedor-Sánchez, J | 1 |
| Afif, N; Chatelus, E; Goetz, J; Lipsker, D; Sibilia, J; Sordet, C; Sparsa, L | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Kerr, OA; Murray, CS; Tidman, MJ | 1 |
| Heath, M; Raugi, GJ | 1 |
| Gensburger, D; Kanitakis, J; Kawashima, M; Marotte, H; Miossec, P | 1 |
| Berthelot, JM; de Quatrebarbes, J; Goëb, V; Joly, P; Le Loët, X; Mejjad, O; Reynaud-Hautin, C; Vittecoq, O | 1 |
| Burrows, NP; Chan, SK; Hazleman, BL | 1 |
| David-Bajar, KM; Elias, AR; Tam, CC | 1 |
| Sticherling, M; Suess, A | 1 |
| Alessi, E; Barbareschi, M; Del Papa, N; Marzano, AV; Ramoni, S | 1 |
2 review(s) available for isoxazoles and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
10 other study(ies) available for isoxazoles and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Leflunomide: psoriasis, lupus.
Topics: Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Psoriasis | 2013 |
[Subacute cutaneous lupus erythematosus induced by golimumab].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Middle Aged; Tumor Necrosis Factor-alpha | 2015 |
Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?
Topics: Antibodies, Antinuclear; Antirheumatic Agents; Chloroquine; Female; Gold; Humans; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Middle Aged; Treatment Outcome | 2011 |
Subacute cutaneous lupus erythematosus associated with leflunomide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Eruptions; Humans; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Male; Middle Aged | 2004 |
Lupus erythematosus with leflunomide: induction or reactivation?
Topics: Antirheumatic Agents; Drug Eruptions; Female; Humans; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Middle Aged; Sjogren's Syndrome; Th1 Cells | 2005 |
Leflunomide-induced subacute cutaneous lupus erythematosus.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Middle Aged | 2005 |
Subacute cutaneous lupus erythematosus precipitated by leflunomide.
Topics: Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Middle Aged | 2005 |
Subacute cutaneous lupus erythematosus associated with leflunomide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Middle Aged | 2005 |
Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin.
Topics: Adult; Aged; Antirheumatic Agents; Diagnosis, Differential; Drug Eruptions; Enzyme Inhibitors; Erythema Multiforme; Female; Fluorescent Antibody Technique, Direct; Humans; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Male; Skin | 2008 |
Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions.
Topics: Adjuvants, Immunologic; Adult; Antibodies, Antinuclear; Biopsy; Diagnosis, Differential; Erythema Multiforme; Female; Fluorescent Antibody Technique, Direct; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Skin; Spondylitis, Ankylosing | 2008 |